PDCD1 and melanoma: Rodriguez-Ruiz et al. previously demonstrated that the combination of radiotherapy with both anti PD1 and anti-CD137 was associated with favorable effects on distant nonirradiated lesions in murine models transplanted with colorectal, melanoma or breast cancer cells [6].